It's important to note that while semaglutide can be a powerful tool in the fight against obesity, it is not a magic solution
Research shows that many people achieve their weight loss goals at 1mg or 1.7mg and choose to stay at that dose long-term
These effects tend to become more pronounced as the dose is gradually increased over subsequent months
For now, the takeaway is this: Wegovy may make it easier for some people to cut back, but its not a proven or standalone treatment for stopping alcohol use
Wegovy is often considered a more affordable alternative, while lifestyle interventions, Orlistat, and liraglutide-based regimens provide safe and cost-effective substitutes for weight management
Reducing Dementia Risk Factors Semaglutide improves key risk factors linked to dementia, including: Blood sugar control Insulin resistance Obesity Cardiovascular health Interestingly, some studies found reduced dementia risk even in people without obesity, suggesting that semaglutides effects may extend beyond weight loss alone
